BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3046496)

  • 1. [Pirarubicin (THP-adriamycin)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2819-27. PubMed ID: 3046496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies of (2''R)-4'-O-tetrahydropyranyl adriamycin (THP).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):237-43. PubMed ID: 3311190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epirubicin (4'-epi-adriamycin].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):151-9. PubMed ID: 2404456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer--chemosensitivity test and a comparative study with doxorubicin].
    Nakashima T; Masuda A; Yano G; Maehara Y
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):633-9. PubMed ID: 8154889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [THP-adriamycin: status of the clinical development of a new anthracycline in France].
    Herait P
    Pathol Biol (Paris); 1990 Jan; 38(1):64-8. PubMed ID: 2308782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology and toxicity of 4'-O-tetrahydropyranyladriamycin.
    Miller AA; Schmidt CG
    Cancer Res; 1987 Mar; 47(5):1461-5. PubMed ID: 3815348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity.
    Greish K; Nagamitsu A; Fang J; Maeda H
    Bioconjug Chem; 2005; 16(1):230-6. PubMed ID: 15656596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer].
    Takeda C
    Gan To Kagaku Ryoho; 1986 May; 13(5):1970-9. PubMed ID: 3707155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Introduction of a new anticancer drug, novantrone].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3163-72. PubMed ID: 3314715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THP-adriamycin in head and neck tumor].
    Honda T; Ohyama W; Sonoda T; Uchida K; Hirokawa T; Takada K; Takeda C
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2538-44. PubMed ID: 6651307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Apr; 42(4):1462-7. PubMed ID: 7060020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T; Kasai Y; Wakui A; Furue H; Majima H; Nitani H; Niijima T; Takeda C; Abe O; Koyama Y
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oriented phase II trial of THP-adriamycin in breast carcinoma.
    Mathé G; Umezawa H; Oka S; Misset JL; Brienza S; de Vassal F; Musset M; Ribaud P; Tapiero H
    Biomed Pharmacother; 1986; 40(10):376-9. PubMed ID: 3580506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of menogaril against various malignant lymphoma cell lines and a human lymphoma xenograft in mice.
    Yoshida M; Fujioka A; Nakano K; Yuasa C; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(5A):2875-9. PubMed ID: 8917401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effect of pirarubicin (THP) against human colon cancer transplanted into nude mice and the mechanism of cell cycle progression].
    Kataoka K; Naomoto Y; Muro M; Kojima K; Horiki S; Hizuta A; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):367-71. PubMed ID: 1543363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of anticancer drugs and combination effects of anthracyclines on the hypoxic cells of head and neck cancer].
    Fujii M; Ohno Y; Kanzaki J
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):647-52. PubMed ID: 7717716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.